ELEVANCE HEALTH, INC. (ELV) Return on equity 2016–2025
ELEVANCE HEALTH, INC. (ELV) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
12.9%FY2025 · since FY2016: 9.8% → 12.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 12.9% | -1.6 pp |
| FY2024 | 14.5% | -0.8 pp |
| FY2023 | 15.2% | -1.0 pp |
| FY2022 | 16.3% | -0.8 pp |
| FY2021 | 17.1% | +3.3 pp |
| FY2020 | 13.8% | -1.4 pp |
| FY2019 | 15.2% | +2.0 pp |
| FY2018 | 13.1% | -1.4 pp |
| FY2017 | 14.5% | +4.7 pp |
| FY2016 | 9.8% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice